The role of α9β1 integrin in modulating epithelial cell behaviour

Journal of Oral Pathology and Medicine

Volumn 40, Issue 10, 2011, Pages 755-761

  Roy, Sushmita ^a   Bingle, Lynne ^a   Marshall, John F ^b   Bass, Rosemary ^c   Ellis, Vincent ^c   Speight, Paul M ^a   Whawell, Simon A ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Integrin; Keratinocytes; Matrix metalloproteinase; Migration; Plasminogen activation

Indexed keywords

ALPHA9BETA1 INTEGRIN; COLLAGEN TYPE 1; GELATINASE A; GELATINASE B; INTEGRIN; LIGAND; PLASMIN; PLASMINOGEN ACTIVATOR; TENASCIN; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ARTICLE; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VECTOR CONTROL; WILD TYPE;

CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN TYPE I; CONNECTIVE TISSUE; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FIBRINOLYSIN; FIBRONECTINS; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA CHAINS; INTEGRINS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MOUTH MUCOSA; MOUTH NEOPLASMS; PEPTIDE FRAGMENTS; TENASCIN; TRANSFECTION; UP-REGULATION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 80955179985     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01050.x     Document Type: Article

References (25)

1. Daley WP, Peters SB, Larsen M. Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci 2008; 121: 255-64.
2. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007; 8: 221-33.
3. Steffensen B, Häkkinen L, Larjava H. Proteolytic events of wound-healing - coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules. Crit Rev Oral Biol Med 2001; 12: 373-98.
4. Palmer EL, Ruegg C, Fernando R, Pytela R, Sheppard D. Sequence and tissue differentiation of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle. J Cell Biol, 1993; 123: 1289-97.
5. Taooka Y, Chen J, Yednock T, Sheppard D. The integrin α9β1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J Cell Biol 1999; 145: 413-20.
6. Yokosaki Y, Matsuura N, Higashiyama S, et al. Identification of the ligand binding site for the integrin α9β1 in the third fibronectin type repeat of tenascin-c. J Biol Chem 1998; 273: 11423-8.
7. Arribas J, Bech-Serra JJ, Santiago-Josefat B. ADAMs cell migration and cancer. Cancer Metastasis Rev 2006; 25: 57-68.
8. Hakkinen L, Hildebrand CH, Berndt A, Kosmehl H, Larjava H. Immunolocalization of tenascin-c, α9 integrin subunit, and αvβ6 integrin during wound healing in human oral mucosa. J Histochem Cytochem 2000; 48: 985-98.
9. Singh P, Chen C, Pal-Ghosh S, Stepp MA, Sheppard D, Van De Water L. Loss of integrin alpha9beta1 results in defects in proliferation, causing poor re-epithelialization during cutaneous wound healing. J Invest Dermatol 2009; 129: 217-28.
10. Thomas GJ, Lewis MP, Whawell SA, et al. Expression of αvβ6 integrin promotes migration and invasion in squamous carcinoma cells. J Invest Dermatol 2001; 117: 67-73.
11. Prime SS, Nixon SVR, Crane IJ, et al. The behaviour of human oral squamous cell carcinoma in cell culture. J Pathol 1990; 160: 259-69.
12. Thomas GJ, Poomsawat S, Lewis MP, Hart IR, Speight PM, Marshal JF. αvβ6 integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes. J Invest Dermatol 2001; 116: 898-904.
13. Basora N, Desloges N, Chang Q, et al. Expresion of the alpha9beta1 integrin in human colonic epithelial cells: resurgence of the fetal phenotype in a subset of colon cancers and adenocarcinoma cell lines. Int J Cancer 1998; 75: 738-43.
14. Dalvi N, Thomas GJ, Marshall JF, et al. Modulation of the urokinase-type plasminogen activator receptor by the β6 integrin subunit. Biochem Biophys Res Commun 2004; 317: 92-9.
15. Gupton SL, Waterman-Storer CM. Spatiotemporal feedback between actomyosin and focal-adhesion systems optimizes rapid cell migration. Cell 2006; 125: 1361-74.
16. Rüegg C, Mariotti A. Vascular integrins: pleiotropic adhesion and signalling molecules in vascular homeostasis and angiogenesis. Cell Mol Life Sci 2003; 60: 1135-57.
17. Aplin AE, Howe AK, Juliano RL. Cell adhesion molecules, signal transduction and cell growth. Curr Opin Cell Biol 1999; 11: 737-44.
18. Thomas GJ, Lewis MP, Hart IR, Marshall JF, Speight PM. αvβ6 integrin promotes invasion of squamous carcinoma cells through upregulation of matrix metalloproteinase-9. Int J Cancer 2001; 92: 641-50.
19. Jones J, Watt FM, Speight PM. Changes in the expression of αv integrins in oral squamous cell carcinoma. J Oral Pathol Med 1997; 26: 63-8.
20. Al-Hazmi N, Thomas GJ, Speight PM, Whawell SA. The 120kDa cell-binding fragment of fibronectin up-regulates migration of alphavbeta6-expressing cells by increasing matrix metalloproteinase-2 and -9 secretion. Eur J Oral Sci 2007; 115: 454-8.
21. Ellis V, Murphy G. Cellular strategies for proteolytic targeting during migration and invasion. FEBS Lett 2001; 506: 1-5.
22. Kajika K, Hirakawa S, Ma B, Drinnenberg I, Detmar M. Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J 2005; 24: 2885-95.
23. Häkkinen L, Kainulainen T, Salo T, Grenman R, Larjava H. Expression of integrin alpha9 subunit and tenascin in oral leukoplakia, lichen planus, and squamous cell carcinoma. Oral Dis 1999; 5: 210-7.
24. Ghosh A, Gkosh S, Maiti GP, et al. Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesion sof the head and neck: clinical and prognostic significance. Cancer Sci 2010; 101: 1511-20.
25. Jones J, Watt FM, Speight PM. Changes in the expression of alpha v integrins in oral squamous cell carcinomas. J Oral Pathol Med 1997; 26: 63-8.